📖 Approx. 11 min ／ Updated 2026.08.16
Business succession for obstetrics and gynecology clinics is closely related to industry-specific challenges such as declining birth rates and a shortage of obstetricians. For current directors struggling with a lack of successors, and for potential acquirers aiming to contribute to regional healthcare, M&A can be a viable option. This article provides a detailed explanation of multifaceted perspectives and practical considerations in obstetrics and gynecology M&A, including the evaluation of facilities handling deliveries, the characteristics of specialized gynecology clinics, and points to note for different types of medical corporations.
Specifics and Market Trends of Obstetrics and Gynecology Clinic M&A
Japanese obstetrics and gynecology medical care faces structural challenges, including a long-term trend of declining birth rates, regional disparities in obstetricians, and excessive workloads. Facilities, particularly privately owned clinics, that handle deliveries are decreasing, making the maintenance of perinatal care in local communities an urgent issue. In this context, M&A is gaining attention as an effective option for resolving succession problems, expanding business scale, or entering new medical fields.
Obstetrics and gynecology is also positioned as a crucial medical function in regional healthcare plans. Enhanced collaboration is required between core hospitals providing advanced perinatal care and clinics handling prenatal check-ups and general gynecological consultations. M&A is expected to optimize the medical service delivery system and promote the effective utilization of medical resources. In particular, the succession of clinics that maintain delivery functions is directly linked to the stable provision of medical care to local residents, making its social significance substantial.
For sellers, M&A can be a means to pass on the results of long-term management efforts to the next generation and retire with peace of mind. For buyers, it offers the advantage of establishing a stable management base more quickly and with reduced risk by inheriting an existing patient base, staff, facilities, and long-standing community trust.
Role of Obstetrics and Gynecology in Regional Healthcare Plans
Regional healthcare plans promoted by the government emphasize the differentiation and collaboration of medical functions. In obstetrics and gynecology, collaboration between core hospitals providing advanced perinatal care and clinics handling prenatal check-ups and general gynecological consultations is essential. M&A is attracting attention as a means to optimize the regional medical service delivery system and promote the effective utilization of medical resources. In particular, the succession of clinics handling deliveries is directly linked to the maintenance of perinatal care in the region, making its importance very high.
Evaluation Points for Clinics Handling Deliveries
The M&A valuation of obstetrics and gynecology clinics that handle deliveries takes into account their high specialization and the resulting unique business conditions. Firstly, in terms of medical fee advantages, delivery-related medical fees are set relatively high, contributing to business stability. However, at the same time, enrollment in the “Maternal Health Care Compensation System” is mandatory, and its cost must also be considered.
In terms of facilities, specialized equipment such as delivery rooms, operating rooms, and recovery rooms are essential, along with a system capable of handling emergencies. Furthermore, a collaborative system with hospitals that have NICU (Neonatal Intensive Care Unit) is an important evaluation point. Regarding staffing, it is crucial whether a highly specialized multidisciplinary team, including not only obstetricians but also midwives, anesthesiologists, and nurses, can be secured and a 24-hour system maintained.
Medical litigation risk is one of the major challenges in perinatal care. The presence or absence of past medical malpractice history and the adequacy of the risk management system (incident/accident reporting system, regular training, etc.) significantly impact the valuation. Additionally, delivery facilities must meet specific facility standards (e.g., collaboration with regional perinatal maternal and child medical centers, requirements for various additional fees), and whether these standards can be maintained after M&A is important.
The valuation in M&A is complexly influenced by high profitability on one hand, and high running costs, medical litigation risks, and the difficulty of securing doctors and midwives on the other. Acquirers must carefully evaluate these risks and costs and concretely consider plans for securing stable personnel after succession.
Evaluation Points for Specialized Gynecology Clinics
The M&A valuation of specialized gynecology clinics emphasizes aspects different from those of facilities handling deliveries. Generally, specialized gynecology clinics tend to have lower business risks because emergency response and medical litigation risks associated with delivery are relatively low.
In terms of revenue, stable outpatient income can be expected from a wide range of patients for regular gynecological check-ups, cervical cancer screenings, menopausal care, infertility consultations, and contraception counseling. Furthermore, in recent years, an increasing number of clinics are seeking to expand revenue by introducing fee-based services such as cosmetic gynecology, supplement prescriptions, and anti-aging treatments, and their diverse service development capabilities are also subject to evaluation.
In terms of capital investment, since large-scale facilities like delivery rooms and operating rooms are often unnecessary, the ability to operate at a relatively low cost is attractive. This makes it easier to achieve efficient management while suppressing initial investment.
In M&A valuation, a stable management base and the potential for diverse medical service development are emphasized. Clinics with strengths in specific specialized fields (e.g., infertility treatment specialists, menopause specialists) tend to be highly valued for their expertise. For acquirers, matching with their own specialization is important, and M&A can provide an opportunity to expand their existing service area or acquire new patient demographics.
| Evaluation Item | Facility Handling Deliveries | Specialized Gynecology Clinic |
|---|---|---|
| Profitability | High unit price, but high personnel and facility costs. Obligation to join the Maternal Health Care Compensation System. | Stable outpatient revenue. Potential for revenue expansion through fee-based services. |
| Capital Investment | Requires large-scale investment, including delivery rooms, operating rooms, and NICU collaboration. | Primarily consultation rooms and diagnostic equipment, relatively low cost. |
| Staffing System | Securing specialists such as obstetricians, midwives, and anesthesiologists is essential. 24-hour response required. | Primarily gynecologists and nurses. Mainly for outpatient hours. |
| Medical Litigation Risk | High risk in perinatal care; risk management is crucial. | Low risk related to deliveries. |
| Regional Healthcare Plan | High importance from the perspective of maintaining perinatal care. Collaboration system is an evaluation target. | Preventive and screening functions as a healthcare hub for local residents are evaluation targets. |
| M&A Difficulty | Tendency to be higher due to complex physician/midwife recruitment and risk assessment. | Tendency to be relatively smoother due to management stability and potential for diverse medical service development. |
Medical Corporation Structure and Business Succession Schemes
When considering business succession for an obstetrics and gynecology clinic, the M&A scheme and procedures differ significantly depending on whether the target is a medical corporation or a private practice. Medical corporations include “medical corporations with equity” and “medical corporations without equity,” each with its own specific points to consider.
In the case of a “medical corporation with equity,” succession primarily occurs through the change of members (shareholders) and the transfer of equity. Equity has a value proportional to the net assets of the medical corporation, making its valuation complex and requiring careful consideration. A change of members requires approval at a general meeting of members and involves procedures such as amending the articles of incorporation. Profits from transferred equity are subject to taxation as capital gains.
On the other hand, for “medical corporations without equity,” since there is no equity, the change of members and directors is the main procedure. In the case of fund contributions, there may be an obligation to refund the fund, which is generally the amount at the time of contribution. Succession of medical corporations of this type typically takes the form of business transfer.
Succession of a private practice is usually carried out through a business transfer scheme. This involves the individual transfer of assets and liabilities such as land, buildings, medical equipment, patient information, and goodwill. In many cases, re-acquisition of licenses is required. Selecting the M&A scheme is crucial and should be decided carefully in consultation with experts, comprehensively considering tax implications, procedural complexity, and post-succession risks.
Key Legal and Tax Considerations in Obstetrics and Gynecology M&A
M&A for obstetrics and gynecology clinics, unlike general business succession, involves numerous specific regulations and treatments under medical and tax laws. Understanding these points in advance and responding appropriately is essential for successful M&A.
First is the **succession of licenses and permits**. When succeeding from a private practice to a medical corporation, or vice versa, re-acquisition of the establishment permit is generally required. Even in the case of business transfer between medical corporations, procedures for changing the operator are necessary. Notifications to the public health center and facility standards to the regional bureau of health and welfare must also be carried out promptly after succession. Failure to do so may hinder the continuation of medical services.
Next is the **re-application and maintenance of facility standards**. It is an important confirmation point whether various additional fees obtained by obstetrics and gynecology clinics (e.g., Maternal Health Care Compensation System, perinatal care fees) and facility standards related to collaboration with specific function hospitals can be maintained after M&A. Detailed confirmation is required to determine whether personnel allocation, facilities, and collaboration systems continue to meet the requirements after acquisition, or if they can be re-acquired.
The **tax treatment** is also complex. Medical corporations are generally exempt from business tax, but some profit-making businesses are taxable. In the case of private practitioners, business tax is levied. Depending on the M&A scheme, tax burdens such as capital gains tax, real estate acquisition tax, and registration license tax can vary significantly. Therefore, it is crucial to consult closely with tax professionals such as tax accountants in advance to select the optimal scheme. In particular, for equity transfers of medical corporations with equity or business transfers of private practices, it is necessary to accurately understand the tax implications on the transfer gains.
These legal and tax issues affect the entire M&A process, making it essential to conduct detailed investigations and assess risks through expert due diligence.
Specific Process and Precautions for Obstetrics and Gynecology Clinic Business Succession
Business succession for obstetrics and gynecology clinics requires incorporating specialized perspectives from the medical industry in addition to the general M&A process. Here, we explain the main processes and particularly important points to note.
- Clarification of Succession Needs and Consultation with Experts
The seller clarifies the reasons for sale and desired conditions, and the buyer clarifies the acquisition objectives and desired areas, then consults with an M&A advisory firm. A non-disclosure agreement is signed to proceed with information disclosure and sharing. - Evaluation of Target Clinic and Negotiation of Terms
Experts comprehensively evaluate profitability, facilities, patient numbers, regional factors, etc., and provide an estimated transfer price. Based on this, negotiations are held between the seller and buyer on basic terms (price, scheme, etc.), and a basic agreement is signed. - Due Diligence (Detailed Investigation)
The buyer conducts a detailed investigation of the target clinic’s finances, legal affairs, labor, medical system, etc. In obstetrics and gynecology, past medical malpractice history, risk management systems, and the retention status of doctors and midwives are strictly examined. - Conclusion of Final Agreement
Based on the due diligence results, the final transfer price, contract terms, etc., are agreed upon, and the final transfer agreement is signed. At this time, procedures for changing medical corporation members and details of the business transfer agreement are finalized. - Closing and Licensing Procedures
Payment of the transfer price and handover of management control take place. Simultaneously, various licensing procedures with administrative agencies, such as changes/re-acquisition of establishment permits and notifications of facility standards, are processed. - Support for Smooth Post-Succession Transition
Even after the M&A is completed, support for smooth operation is important, including explanations to patients and staff, and support for the transition of the medical system. A handover period is usually set for a certain duration.
Particularly important points to note are: first, accurately evaluating the specific medical risks of obstetrics and gynecology. Confirmation of past medical malpractice history and risk management systems must be thorough. Second, creating concrete plans for the handover of specialized staff such as doctors and midwives, and their securing after succession. Staff shortages directly impact the medical service system, requiring meticulous planning. Third, providing sufficient consideration and information to patients. After succession, careful explanations and support during the transition period are essential so that patients can continue to receive care with peace of mind. Finally, it is important not to forget the perspective of contributing to regional healthcare and to strive for M&A to be beneficial to the local community.
Business succession for obstetrics and gynecology clinics requires many specialized insights different from general M&A due to the highly specialized medical field. At M&A Medical, consultants with extensive experience and specialized knowledge in the medical industry will propose the optimal succession plan tailored to your clinic’s situation. From vague concerns to specific consultations, please feel free to contact us. We offer free consultations with strict confidentiality.
For Medical Succession Consultations, Contact M&A Medical
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the success of transfers from clinics and medical corporations facing succession issues to strategic acquisitions on a success fee basis.
- Initial consultation and preliminary appraisal are free
- No retainer or monthly fees (success fee only)
- Strict confidentiality (proceeding under NDA)
- Support for all 47 prefectures and all medical specialties
Please consult us early, even if you only want to know the market price, have no successor, or are considering joining a group. We handle everything from initial inquiries to final contract signing.